Across TCGA pan-cancer cohorts, MCRIP1 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated MCRIP1 data layer compared with 23 for mass-spec protein and 6 for mass-spec protein.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher MCRIP1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated MCRIP1 expression acts as an unfavorable survival marker.
UCEC are the cancer types where MCRIP1 Mutation most reproducibly stratifies survival.